Resmed Inc
NYSE:RMD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
152.57
256.07
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Resmed Inc
Resmed Inc
Free Cash Flow
Resmed Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Resmed Inc
NYSE:RMD
|
Free Cash Flow
$1.3B
|
CAGR 3-Years
50%
|
CAGR 5-Years
23%
|
CAGR 10-Years
16%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Free Cash Flow
$3.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Free Cash Flow
$2.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
28%
|
CAGR 10-Years
10%
|
|
|
Stryker Corp
NYSE:SYK
|
Free Cash Flow
$3.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Free Cash Flow
$5.7B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Free Cash Flow
$586m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-1%
|
|
Resmed Inc
Glance View
ResMed Inc. is a leading global company dedicated to transforming the lives of individuals suffering from sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Founded in 1989, ResMed has consistently innovated in the development of cutting-edge devices and cloud-connected software that enable patients to monitor their health and improve their quality of life. The company’s flagship products, including CPAP machines and adaptive cloud-based solutions, make it easier for patients to adhere to therapy while providing valuable data to healthcare providers. This commitment to integrating technology with healthcare has positioned ResMed as a key player in the booming health tech industry, appealing to both patients and investors alike. As the demand for effective respiratory therapy solutions continues to grow, driven by rising incidences of sleep disorders and an aging global population, ResMed stands out with its strong market presence and strategic focus on digital health. The company's agile approach allows it to swiftly adapt to changing market dynamics, evidenced by its expansion into software solutions that enhance patient management and clinical outcomes. With a robust balance sheet and a commitment to sustainable growth, ResMed not only offers potential for solid long-term returns but also embodies the principles of value investing that resonate with discerning investors. As the landscape of healthcare evolves, ResMed is poised to remain at the forefront, making it a compelling option for those looking to invest in the future of health technology.
See Also
What is Resmed Inc's Free Cash Flow?
Free Cash Flow
1.3B
USD
Based on the financial report for Sep 30, 2024, Resmed Inc's Free Cash Flow amounts to 1.3B USD.
What is Resmed Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
16%
Over the last year, the Free Cash Flow growth was 70%. The average annual Free Cash Flow growth rates for Resmed Inc have been 50% over the past three years , 23% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
